Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency
Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2022-11-01
|
| Col·lecció: | Медицинская иммунология |
| Matèries: | |
| Accés en línia: | https://www.mimmun.ru/mimmun/article/view/2514 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|